Secretome Therapeutics, a clinical-stage biotechnology company developing novel therapies derived from neonatal cardiac ...
Q32 Bio raised approximately $55 million in a private placement led by major healthcare investors as the company continues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results